Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer

SIMPLE SUMMARY: Anti-angiogenic therapies targeting the vascular endothelial growth factor (VEGF) signaling are established in the arsenal of cancer treatments. Despite the expectations, their benefits are temporary in cancer patients, partly due to the compensatory function of other angiogenic grow...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahra, Fatema Tuz, Sajib, Md. Sanaullah, Mikelis, Constantinos M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003808/
https://www.ncbi.nlm.nih.gov/pubmed/33804681
http://dx.doi.org/10.3390/cancers13061422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003808/
https://www.ncbi.nlm.nih.gov/pubmed/33804681
http://dx.doi.org/10.3390/cancers13061422

Ejemplares similares